Journal of Cutaneous Pathology | 2021
Cutaneous acral myofibroma with PDGFRB mutation in a patient with linear morphea en coup de sabre
Abstract
REFERENCES 1. Lodha S, Saggar S, Celebi JT, Silvers DN. Discordance in the histopathologic diagnosis of difficult melanocytic neoplasms in the clinical setting. J Cutan Pathol. 2008;35(4):349-352. 2. Vidal CI, Armbrect EA, Andea AA, et al. Appropriate use criteria in dermatopathology: initial recommendations from the American Society of Dermatopathology. J Cutan Pathol. 2018;45(8):563-580. 3. Emanuel PO, Andea AA, Vidal CI, et al. Evidence behind the use of molecular tests in melanocytic lesions and practice patterns of these tests by dermatopathologists. J Cutan Pathol. 2018;45(11):839-846. 4. Cockerell CJ, Tschen J, Evans B, et al. The influence of a gene expression signature on the diagnosis and recommended treatment of melanocytic tumors by dermatopathologists. Medicine (Baltimore). 2016;95(40):e4887. 5. Soura E, Eliades PJ, Shannon K, Stratigos AJ, Tsao H. Hereditary melanoma: update on syndromes and management: genetics of familial atypical multiple mole melanoma syndrome. J Am Acad Dermatol. 2016;74(3):395-407. 6. Koh SS, Cassarino DS. Immunohistochemical expression of p16 in melanocytic lesions: an updated review and meta-analysis. Arch Pathol Lab Med. 2018;142(7):815-828. 7. Reed JA, Loganzo F Jr, Shea CR, et al. Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression. Cancer Res. 1995;55(13):2713-2718. 8. Shain AH, Yeh I, Kovalyshyn I, et al. The genetic evolution of melanoma from precursor lesions. N Engl J Med. 2015;373(20):1926-1936. 9. Carney PA, Frederick PD, Reisch LM, et al. How concerns and experiences with medical malpractice affect dermatopathologists perceptions of their diagnostic practices when interpreting cutaneous melanocytic lesions. J Am Acad Dermatol. 2016;74(2):317-324. 10. Santillan AA, Messina JL, Marzban SS, Crespo G, Sondak VK, Zager JS. Pathology review of thin melanoma and melanoma in situ in a multidisciplinary melanoma clinic: impact on treatment decisions. J Clin Oncol. 2010;28(3):481-486.